Throughout the last three months, 5 analysts have evaluated ResMed (NYSE:RMD), offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their recent ...
In the latest quarter, 5 analysts provided ratings for ResMed (NYSE:RMD), showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing ...
Across the recent three months, 7 analysts have shared their insights on ResMed (NYSE:RMD), expressing a variety of opinions spanning from bullish to bearish. The following table encapsulates their ...
Across the recent three months, 9 analysts have shared their insights on ResMed (NYSE:RMD), expressing a variety of opinions spanning from bullish to bearish. The table below offers a condensed view ...
Resmed Inc ((RMD)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results